Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates
09:11am, Thursday, 31'st Oct 2024
Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $2 per share a year ago.
Bristol Myers's stock pops as earnings top estimates and company raises guidance
08:03am, Thursday, 31'st Oct 2024
The company says it “made important strides in the third quarter.”
Bristol Myers Stock Rises After Earnings Beat, Guidance Hike
07:40am, Thursday, 31'st Oct 2024
The pharmaceutical company posted third-quarter adjusted earnings a share of $1.80 on revenue of $11.9 billion.
Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs
07:19am, Thursday, 31'st Oct 2024
Bristol Myers Squibb posted better-than-expected third-quarter earnings on Thursday citing strong sales of established drugs like blood thinner Eliquis and cancer treatment Revlimid as well as newer d
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
07:01am, Thursday, 31'st Oct 2024
Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term gro
Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?
03:01pm, Monday, 28'th Oct 2024
BMY is looking to turnaround its business, banking on the strong uptake of new drugs. The recent spate of positive regulatory updates also bodes well for the stock, and we recommend it to investors.
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
01:10pm, Monday, 28'th Oct 2024
Let's look at five pharma and drug companies, PFE, LLY, ABBV, MRK and BMY, that are scheduled to release their third-quarter 2024 results this week.
Curious about Bristol Myers (BMY) Q3 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Monday, 28'th Oct 2024
Besides Wall Street's top -and-bottom-line estimates for Bristol Myers (BMY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during t
Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren
09:00am, Monday, 28'th Oct 2024
Bristol-Myers Squibb, an American multinational pharmaceutical company that discovers, develops, and markets drugs for various therapeutic areas, is now a $108 billion (by market cap) Big Pharma giant
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
06:59am, Monday, 28'th Oct 2024
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #COBENFY--Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024.
Bristol Myers Squibb's Q3 Earnings Are Likely To Be Strong
08:30am, Friday, 25'th Oct 2024
Bristol Myers Squibb remains undervalued with strong long-term potential, despite recent stock price declines and market skepticism about its growth prospects. The company reported strong Q2 FY2024 re
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 24'th Oct 2024
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
10:05am, Wednesday, 23'rd Oct 2024
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Bristol Myers (BMY) Upgraded to Buy: Here's What You Should Know
01:06pm, Tuesday, 22'nd Oct 2024
Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BMY or VRTX: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 22'nd Oct 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Vertex Pharmaceuticals (VRTX). But which of these two stocks offers v
